Wohl D, et al. Patient-reported outcomes among HIV-1-infected adults randomized to B/F/TAF versus DTG/ABC/3TC in two Phase 3 controlled clinical trials over 48 weeks. AIDS 2018.
Effect van onderbreking methotrexaat op de immuniteit na de COVID-19-booster
jan 2023 | Psoriasis, RA, Vaccinatie, Virale infecties